Printer Friendly

Handbook of Bioequivalence Testing, 2nd Edition.


Handbook of Bioequivalence Testing, 2nd Edition

Sarfaraz K. Niazi

CRC Press


955 pages



Drugs and the Pharmaceutical Sciences


Niazi, an author, patent law practitioner, and inventor who heads an organization that develops and manufactures biosimilar recombinant drugs, presents a handbook that details aspects of bioequivalence testing, including the physicochemical basis; drug delivery factors; pharmacokinetic/pharmacodynamic modeling; the rationale and principles; bioequivalence waivers; statistical evaluation; the regulatory inspection process; food effect bioequivalence studies; testing of topical drugs and nasal products; the US, European, and international perspectives on testing; protocols; documentation; laboratory and clinical practice; and method, computer, and software validation. This edition has been updated to include new findings in drug delivery and dosage form design and revised worldwide regulatory requirements, as well as new topics like the history of generic pharmaceuticals, new guidelines for submissions related to bioequivalency studies, models of noninferiority, the biosimilarity of large molecule drugs, the bioequivalence of complementary and alternative medicines, biosimilar therapeutic proteins and monoclonal antibodies, new FDA guidelines for bioanalytical method validation, outsourcing and monitoring bioequivalence studies, and the future of the field. ([umlaut] Ringgold, Inc., Portland, OR)

COPYRIGHT 2015 Ringgold, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Article Type:Brief article
Date:Feb 1, 2015
Previous Article:The Synoptic Problem and Statistics.
Next Article:Cell and Matrix Mechanics.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters